Search for: "KBI-E INC." Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Dec 2013, 8:02 pm by Patent Docs
Kremers Urban Pharmaceuticals, Inc. et al. 3:13-cv-07299; filed December 3, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
25 Mar 2012, 9:25 pm by Patent Docs
Mylan Laboratories Ltd. et al. 1:12-cv-00300; filed March 12, 2012 in the District Court of Delaware • Plaintiffs: AstraZeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
27 Oct 2013, 9:55 pm by Patent Docs
Lupin Ltd. et al. 3:13-cv-06315; filed October 23, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Astrazeneca LP; KBI-E Inc.; Pozen, Inc. [read post]
7 Aug 2011, 8:36 pm by Patent Docs
., Unit III et al. 3:11-cv-04468; filed August 2, 2011 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
24 Mar 2013, 8:01 pm by Patent Docs
Watson Laboratories, Inc. - Florida et al. 3:13-cv-01669; filed March 19, 2013 in the District Court of New Jersey • Plaintiffs: AstraZeneca AB; Aktiebolaget Hassle; AstraZeneca LP; KBI Inc.; KBI-E Inc. [read post]
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
15 Mar 2020, 8:59 pm by Omar Ha-Redeye
Canada has come a long way since the SARS pandemic in 2003. [read post]